Alabama’s Medical Cannabis Licensing Process to be Disputed in Court Today

December 28, 2023 · Ganjapreneur

In the latest development from Alabama’s nascent medical cannabis industry, several companies including Southeast Cannabis, TheraTrue 3 Notch Root, Alabama Always, and Jemmstone are set to make their legal case against the Alabama Medical Cannabis Commission (AMCC) today, as reported by the Alabama Political Reporter. The applicants are contesting the commission’s methods of awarding medical cannabis licenses, asserting that the AMCC’s decisions during a crucial December 12 meeting were procedurally flawed, specifically criticizing the handling of application scoring and electronic files, as well as a restrictive 10MB limit on submission portals.

Alabama Always, LLC is also seeking expedited discovery in its lawsuit against the AMCC, alleging violations of the Alabama Administrative Procedure Act and the Open Meetings Act. They argue that this discovery is essential to challenge the Commission’s rejection of their license application effectively. Concurrently, 3 Notch Roots and Jemmstone are looking to consolidate their cases with Alabama Always, as they are addressing similar grievances against the AMCC’s actions.

This series of lawsuits is indicative of growing discontent with the AMCC’s transparency and fairness, potentially setting the stage for a major legal battle. Earlier this month the AMCC made headlines with their decision to award Trulieve — a publicly-traded company out of Florida — the only license reserved for “minority-owned” businesses. Cannabis operators from Alabama and other states decried the decision, pointing out that large corporate brands should not be allowed to capitalize on licensing provisions intended to boost market diversity.

The outcomes of today’s hearings are anticipated to have far-reaching implications not only for Alabama’s medical cannabis industry but also for the national conversation around how a legalized cannabis market should function, and who should be granted opportunities to participate. (Full Story)

In category:Medical
Tags:
Next Post

Johns Hopkins University To Spend $10 Million Studying Medical Cannabis

A new multi-million dollar study at Johns Hopkins University aims to analyze how patients nationwide respond to medical cannabis treatments.  Johns Hopkins University, which championed one of the largest and most widely referenced studies on medical applications of psilocybin mushrooms,…
Read
Previous Post

Top GOP Wisconsin Lawmaker Is ‘Pretty Confident’ Medical Marijuana Bill Will Pass Next Year With ‘Just Republican Votes’

The GOP leader of Wisconsin’s Assembly says a limited medical marijuana bill will be introduced next month—though he expects that lawmakers are “going to have to pass it with just Republican votes” because his Democratic colleagues want broader legalization and…
Read
Random Post

DEA Slammed Over Post Commemorating Nixon’s Drug War Legacy On First Day Of Black History Month

The Drug Enforcement Administration (DEA) is facing criticism over its decision to commemorate President Richard Nixon’s drug war legacy in a social media post that coincided with the beginning of Black History Month. DEA’s Throwback Thursday (or TBT) post on…
Read
Random Post

How Many People Does It Take to Deliver an Order of Cannabis? A.4 B.2 C.1?

In a decisive 3-1 vote, Massachusetts regulators have given the green light to cannabis transport businesses to streamline their delivery operations by reducing the mandatory two-person team to a single cannbais delivery driver. This potential cost-cutting measure is poised to benefit…
Read
Random Post

Nevada GOP Governor’s Office Discusses Psychedelics Work Group Vacancies With Advocates Amid Push For Broader Legalization

Nevada psychedelics activists say they’ve had a “productive meeting” with the Republican governor’s office about the need to expeditiously form a task force under a law enacted earlier this year in order to inform future reform—including the possible legalization of…
Read
Random Post

Big investors keener on cannabis MSOs as rescheduling looms, survey shows

Institutional investors are increasingly bullish on U.S. cannabis multistate operators, according to a new survey, which suggests marijuana rescheduling by the federal government could convince those big investors to put new money into MSOs. The group’s sentiment is “more bullish…
Read